- Home
- NVO vs AXP Comparison
NVO vs AXP Comparison
Compare NVO & AXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVO
- AXP
- Stock Information
- Founded
- NVO 1923
- AXP 1850
- Country
- NVO Denmark
- AXP United States
- Employees
- NVO N/A
- AXP N/A
- Industry
- NVO Biotechnology: Biological Products (No Diagnostic Substances)
- AXP Finance: Consumer Services
- Sector
- NVO Health Care
- AXP Finance
- Exchange
- NVO Nasdaq
- AXP Nasdaq
- Market Cap
- NVO 278.0B
- AXP 227.7B
- IPO Year
- NVO N/A
- AXP N/A
- Fundamental
- Price
- NVO $59.29
- AXP $328.12
- Analyst Decision
- NVO Buy
- AXP Buy
- Analyst Count
- NVO 9
- AXP 22
- Target Price
- NVO $82.20
- AXP $318.14
- AVG Volume (30 Days)
- NVO 15.4M
- AXP 2.6M
- Earning Date
- NVO 11-05-2025
- AXP 10-17-2025
- Dividend Yield
- NVO 2.08%
- AXP 1.00%
- EPS Growth
- NVO 24.25
- AXP 6.22
- EPS
- NVO 3.93
- AXP 14.23
- Revenue
- NVO $49,108,936,497.00
- AXP $63,435,000,000.00
- Revenue This Year
- NVO $9.58
- AXP $18.98
- Revenue Next Year
- NVO $7.39
- AXP $8.33
- P/E Ratio
- NVO $15.02
- AXP $23.05
- Revenue Growth
- NVO 20.91
- AXP 9.17
- 52 Week Low
- NVO $45.05
- AXP $220.43
- 52 Week High
- NVO $120.56
- AXP $349.19
- Technical
- Relative Strength Index (RSI)
- NVO 55.41
- AXP 47.95
- Support Level
- NVO $53.77
- AXP $326.28
- Resistance Level
- NVO $60.90
- AXP $344.85
- Average True Range (ATR)
- NVO 1.54
- AXP 7.18
- MACD
- NVO 0.25
- AXP -2.19
- Stochastic Oscillator
- NVO 64.90
- AXP 6.91
About NVO Novo Nordisk A/S
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About AXP American Express Company
American Express is a global financial institution, operating in about 130 countries, that provides consumers and businesses charge and credit card payment products. The company also operates a highly profitable merchant payment network. The firm operates in four segments: US consumer services, US commercial services, international card services, and global merchant and network services. In addition to payment products, the company's commercial business offers expense management tools, consulting services, and business loans.